Sign in
4

Changes in Ownership

Cocrystal Pharma, Inc. Filed Acc 0001493152-26-002033

Options or other derivatives

  • Director acquired 16,410 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Rubin Steven D Director 2026-01-09 Grant or award · Stock Options (Right to Buy) +16,410 16,410 D
Loading xslF345X05/ownership.xml…